Validation of a New Risk Score to Predict Contrast-Induced Nephropathy After Percutaneous Coronary Intervention
Dimitrios Tziakas, Stavros Konstantinides(Johannes Gutenberg University Mainz), Ploumis Passadakis(Democritus University of Thrace), Xavier García–Moll(Hospital de Sant Pau), Antonio Serra, Sofia Chatzikyriakou(Clinique Saint Jean), Goran Stanković(University of Belgrade), Nasir Sıvrı(Trakya University), Dimitrios Stakos(Democritus University of Thrace), Ertan Yetkın(Memorial Sisli Hospital), Zlatko Mehmedbegović, Vassilis Vargemezis(Democritus University of Thrace), Armağan Altun(Trakya University), Elias Thodis(Democritus University of Thrace), Mustafa Gür(Mersin Üniversitesi), Vassilis Voudris(Onassis Cardiac Surgery Center), Juan Carlos Kaski(University of London), Georgios Chalikias(Democritus University of Thrace)
Cited by 47
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
|European Respiratory Journal|2019|1.6k
Complete Revascularization with Multivessel PCI for Myocardial Infarction
|New England Journal of Medicine|2019|926
Contemporary Management of Acute Right Ventricular Failure: A Statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology
|European Journal of Heart Failure|2016|708
Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy
|New England Journal of Medicine|2015|650